
### [MONDO:0002010](http://purl.obolibrary.org/obo/MONDO_0002010)
**Label:** FG syndrome

**Subclasses:** [MONDO:0010590](http://purl.obolibrary.org/obo/MONDO_0010590) (FG syndrome 1), [MONDO:0010318](http://purl.obolibrary.org/obo/MONDO_0010318) (FG syndrome 4), [MONDO:0010297](http://purl.obolibrary.org/obo/MONDO_0010297) (FG syndrome 2), [MONDO:0010366](http://purl.obolibrary.org/obo/MONDO_0010366) (FG syndrome 5), [MONDO:0010316](http://purl.obolibrary.org/obo/MONDO_0010316) (FG syndrome 3), 

**Mapped go classes:** [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity), [GO:0002761](http://purl.obolibrary.org/obo/GO_0002761) (regulation of myeloid leukocyte differentiation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0016592](http://purl.obolibrary.org/obo/GO_0016592) (mediator complex), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), 

**Class expressions from DL-Learner:**

- [GO:0090579](http://purl.obolibrary.org/obo/GO_0090579) (dsDNA loop formation) 52.94%
- [GO:0090202](http://purl.obolibrary.org/obo/GO_0090202) (gene looping) 52.94%
- [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping) 52.94%
- [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation) 52.94%
- [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis) 52.94%
- [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis) 52.94%
- [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development) 52.94%
- [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis) 52.94%
- [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis) 52.94%
- [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development) 52.94%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 52.94%
- [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development) 52.94%
- [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development) 52.94%
- [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation) 52.94%
- [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development) 52.94%


